Participant flow16

How many started, completed or left each group, period by period.

1 to 16 of 16

Period	Milestone	Group	Participants
Overall Study	STARTED	Placebo	77
Overall Study	STARTED	AMG 827 140 mg	75
Overall Study	STARTED	AMG 827 210 mg	76
Overall Study	STARTED	AMG 827 280 mg	77
Overall Study	Participants Who Received Study Treatment	Placebo	76
Overall Study	Participants Who Received Study Treatment	AMG 827 140 mg	74
Overall Study	Participants Who Received Study Treatment	AMG 827 210 mg	76
Overall Study	Participants Who Received Study Treatment	AMG 827 280 mg	76
Overall Study	COMPLETED	Placebo	68
Overall Study	COMPLETED	AMG 827 140 mg	68
Overall Study	COMPLETED	AMG 827 210 mg	71
Overall Study	COMPLETED	AMG 827 280 mg	65
Overall Study	NOT COMPLETED	Placebo	9
Overall Study	NOT COMPLETED	AMG 827 140 mg	7
Overall Study	NOT COMPLETED	AMG 827 210 mg	5
Overall Study	NOT COMPLETED	AMG 827 280 mg	12

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01199289/flow